Skip to main content

Advertisement

Table 4 Treatment-emergent adverse events by age group

From: Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

  N (%)  
Event Age 18 – 64 (n = 1178) Age ≥ 65 (n = 101) p-Value
Nausea 406 (34.5) 29 (28.7) .274
Insomnia 378 (32.1) 22 (21.8) .034
Headache 373 (31.7) 16 (15.8) <.001
Somnolence 358 (30.4) 23 (22.8) .114
Dry mouth 282 (23.9) 18 (17.8) .180
Dizziness 267 (22. 7) 31 (30.7) .085
Constipation 250 (21.2) 23 (22.8) .705
Increased sweating 177 (15.0) 15 (14.9) 1.00
Anxiety 176 (14.9) 10 (9.9) .188
Diarrhea 157 (13.3) 17 (16.8) .363
Fatigue 125 (10.6) 9 (8.9) .735
  1. † Events with an occurrence > 10% in Weeks 1–52.